The new independent entity will be led by Que Dallara, the current head of Medtronic's diabetes division, and is expected to employ approximately 8,000 people. Its headquarters will be located in ...

Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

Medtronic expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million over ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk of death from any cause compared to those who took the other type of ...

Medtronic, a healthcare technology company based in Ireland, plans to separate its diabetes business into a standalone, publicly traded company by the end of 2026.  The company announced the move May ...

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

Medtronic (NYSE:MDT) reported better-than-expected fiscal Q4 earnings and revenue, while unveiling plans to spin off its ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...